+499.5%
MRNA vs NTRA
+96.0%
+403.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NTRA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.2% | -2.4% | -2.3% |
| 7D | +5.5% | +0.6% | +4.9% | +4.9% |
| 30D | +158.7% | +19.5% | +139.2% | +140.6% |
| 3M | +182.1% | +47.8% | +134.4% | +145.9% |
| 6M | +151.8% | +61.6% | +90.2% | +109.0% |
| YTD | +393.6% | +43.3% | +350.3% | +335.4% |
| 1Y | +499.5% | +97.0% | +402.4% | +371.9% |
| All | +499.5% | +96.0% | +403.5% | +371.9% |
Cumulative growth
Daily Returns
Daily percentage return beside NTRA.
Daily Out/Under-Performance
Portfolio return minus NTRA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTRA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NTRA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling